Literature DB >> 19385280

Canine vascular neoplasia--a population-based clinicopathologic study of 439 tumours and tumour-like lesions in 420 dogs.

Hans Gamlem1, Knut Nordstoga, Kristen Arnesen.   

Abstract

This paper deals with a population-based material collected during the years 1990-1998, and comprises 439 tumours and tumour-like vascular processes from 420 dogs. Anatomic location, age, breed and gender are reported. A distinction is made between benign neoplasms, tumours of intermediate malignancy, and obvious malignant processes (angiosarcomas). Clinical behaviour, comprising recurrence and metastatic disposition, is included. Subclassification is done according to criteria used in human oncology. More than one half (242 of 439) occurred in the skin, and a great majority of skin processes (223 of 242) represented benign tumours or tumour-like lesions. The next most common site of summarised lesions was the spleen, with 110 cases, with only 17 processes in this organ being defined as benign. Splenic involvement was followed by the liver, with 13 out of 17 processes being angiosarcomas. Eleven of 12 heart tumours were angiosarcomas. A majority of skin haemangiomas was of the cavernous type (108 of 211), and more than one half (10 of 14) of the capillary haemangiomas were located on dorsal sites of the extremities. The mixed capillary/cavernous haemangiomas had a more diffuse distribution, although 20 of 31 were found in the skin of the hind limbs. Only one lymphangioma and one case of angiomatosis were observed. Most tumour-like proliferations were papillary endothelial hyperplasias. Recurrence occurred in 17 dogs, some of which had received a primary benign diagnosis. Primary metastases were observed in 63 animals, the majority in the spleen and heart. Dissemination involved a further 23 cases (22 had angiosarcoma). The male/female rate of benign tumours was 0.78, for tumour-like processes 1.83, intermediate malignant tumours 1.65, and angiosarcomas 1.60. With few exceptions, there was an overweight of all subclassified vascular lesions in animals more than 6 years of age.

Entities:  

Mesh:

Year:  2008        PMID: 19385280     DOI: 10.1111/j.1600-0463.2008.125m4.x

Source DB:  PubMed          Journal:  APMIS Suppl        ISSN: 0903-465X


  5 in total

1.  Gene expression profiles of beta-adrenergic receptors in canine vascular tumors: a preliminary study.

Authors:  Jordi Clanxet; Mariana Teles; Javier Hernández-Losa; Manuel Ruiz-Echarri Rueda; Luis Benitez-Fusté; Josep Pastor
Journal:  BMC Vet Res       Date:  2022-05-30       Impact factor: 2.792

2.  Integrating databases for research on health and performance in small animals and horses in the Nordic countries.

Authors:  Agneta Egenvall; Ane Nødtvedt; Lars Roepstorff; Brenda Bonnett
Journal:  Acta Vet Scand       Date:  2011-06-20       Impact factor: 1.695

3.  Immunohistochemical detection of p53 and pp53 Ser392 in canine hemangiomas and hemangiosarcomas located in the skin.

Authors:  María José García-Iglesias; Jose Luis Cuevas-Higuera; Ana Bastida-Sáenz; María Gracia de Garnica-García; Laura Polledo; Paula Perero; Jorge González-Fernández; Beatriz Fernández-Martínez; Claudia Pérez-Martínez
Journal:  BMC Vet Res       Date:  2020-07-13       Impact factor: 2.741

4.  Prevalence, distribution, and clinical characteristics of hemangiosarcoma-associated skeletal muscle metastases in 61 dogs: A whole body computed tomographic study.

Authors:  Andrea Carloni; Rossella Terragni; Antonio Maria Morselli-Labate; Michaela Paninarova; John Graham; Paola Valenti; Monica Alberti; Giulia Albarello; Francesca Millanta; Massimo Vignoli
Journal:  J Vet Intern Med       Date:  2019-02-22       Impact factor: 3.333

5.  MicroRNA-214 Promotes Apoptosis in Canine Hemangiosarcoma by Targeting the COP1-p53 Axis.

Authors:  Kazuki Heishima; Takashi Mori; Hiroki Sakai; Nobuhiko Sugito; Mami Murakami; Nami Yamada; Yukihiro Akao; Kohji Maruo
Journal:  PLoS One       Date:  2015-09-03       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.